NEW YORK–(BUSINESS WIRE)–Orbsen Therapeutics Limited, a leading immunotherapy company focused on the development of cell therapies for diabetic and autoimmune diseases has announced that it is part of a consortium awarded a UKE7M grant from the UK Government’s Innovate UK program. […]